According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.18204. At the end of 2023 the company had a P/S ratio of 5.82.
Year | P/S ratio | Change |
---|---|---|
2023 | 5.82 | -6.07% |
2022 | 6.20 | -77.22% |
2021 | 27.2 | -39.44% |
2020 | 44.9 | 31.28% |
2019 | 34.2 | -3.75% |
2018 | 35.6 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Neogen NEOG | 3.91 | -36.77% | ๐บ๐ธ USA |
Natera NTRA | 11.2 | 81.49% | ๐บ๐ธ USA |